Stem Cells, Dr.Newman - Brenda Silcox
To learn more about the products and to order products, OR to partner with me RIGHT NOW and start earning money free product from your Jeunesse Global business, click here: http://www.brendasilco...
By: Brenda Silcox
Stemlife baby cord blood stem cells 3
Stemlife baby cord blood stem cells 3.
By: debbseven
Read the original:
Stemlife baby cord blood stem cells 3 - Video
A.P.REYES, MD ~U.S.SENATOR, LEGALIZING STEM CELL THERAPY IN U.S.A.
I created this video with the YouTube Slideshow Creator (http://www.youtube.com/upload)
By: Arturo Reyes
Original post:
A.P.REYES, MD ~U.S.SENATOR, LEGALIZING STEM CELL THERAPY IN U.S.A. - Video
Obesity Weight (Stem Cell Therapy)
The subject matter of this video Obesity Weight.
By: Mohammad Sadique
Read the original post:
Obesity & Weight (Stem Cell Therapy) - Video
Beverly Hills, CA (PRWEB) June 16, 2014
The top stem cell doctors at Beverly Hills Orthopedic Institute are now offering regenerative medicine procedures for Achilles tendonitis and tears. The procedures include options for several types of stem cell procedures that can provide pain relief and help patients avoid surgery. Call (310) 438-5343 for more information and scheduling.
Achilles tendonitis or tears may bother patients for many months and not respond well to traditional treatments. This may include NSAIDS, bracing and steroid injections. While surgery for these conditions may be extremely successful, there is often a considerable rehabilitation and potential surgery complications.
Stem cell injections for Achilles tears or tendonitis have been a revolutionary treatment. This may include bone marrow derived injections, or amniotic derived stem cell procedures. Both offer exceptional concentrations of stem cells, growth factors and additional reparative materials.
The procedures are performed as an outpatient, with the amniotic derived material coming from consenting donors after scheduled c-sections. There is no fetal material used, negating any ethical concerns.
Dr. Raj at Beverly Hills Orthopedic Institute is a Double Board Certified orthopedic doctor. He treats patients from weekend warriors to amateur and professional athletes, along with celebrities, executives, manual laborers and grandparents.
For more information and scheduling, call (310) 438-5343.
SOURCE: BrainStorm Cell Therapeutics, Inc.
NEW YORK, NY and PETACH TIKVAH, ISRAEL--(Marketwired - Jun 10, 2014) - BrainStorm Cell Therapeutics (OTCQB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that it has initiated a study in a mouse model of autism at the Felsenstein Medical Research Center, Sackler Faculty of Medicine, Tel Aviv University, under the direction of Professor Daniel Offen. The study will explore the effects of the company's "MSC-NTF" cells on mouse behavior.
The study, which will be conducted using the BTBR mouse model for autism, will investigate repetitive behavior, increased cognitive flexibility and improved sociability in mice after administration of a single intracerebroventricular injection of the cells.
Autism is a spectrum of disorders characterized by marked abnormalities in communication and social interactions. Stem cell-based regenerative therapy has been proposed for the treatment of autism, as studies have shown that cell transplantation may affect molecular processes associated with autism pathophysiology. In addition, immune dysfunction has been confirmed with autistic children, and mesenchymal stem cells are known to regulate the immune system. Stem cell research in autism is being conducted at several regenerative medicine research centers including the California Institute of Regenerative Medicine (CIRM).
About BrainStorm Cell Therapeutics, Inc. BrainStorm Cell Therapeutics Inc. is a biotechnology company engaged in the development of first-of-its-kind adult stem cell therapies derived from autologous bone marrow cells for the treatment of neurodegenerative diseases. The Company holds the rights to develop and commercialize its NurOwn technology through an exclusive, worldwide licensing agreement with Ramot, the technology transfer company of Tel Aviv University. For more information, visit the company's website at http://www.brainstorm-cell.com.
Safe Harbor Statement Statements in this announcement other than historical data and information constitute "forward-looking statements" and involve risks and uncertainties that could cause BrainStorm Cell Therapeutics Inc.'s actual results to differ materially from those stated or implied by such forward-looking statements. Terms and phrases such as "may", "should", "would", "could", "will", "expect", "likely", "believe", "plan", "estimate", "predict", "potential",and similar terms and phrases are intended to identify these forward-looking statements.The potential risks and uncertainties include, without limitation, risks associated with BrainStorm's limited operating history, history of losses; minimal working capital, dependence on its license to Ramot's technology; ability to adequately protect the technology; dependence on key executives and on its scientific consultants; ability to obtain required regulatory approvals; and other factors detailed in BrainStorm's annual report on Form 10-K and quarterly reports on Form 10-Q available at http://www.sec.gov.These factors should be considered carefully, and readers should not place undue reliance on BrainStorm's forward-looking statements.The forward-looking statements contained in this press release are based on the beliefs, expectations and opinions of management as of the date of this press release. We do not assume any obligation to update forward-looking statements to reflect actual results or assumptions if circumstances or management's beliefs, expectations or opinions should change, unless otherwise required by law. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements.
Read more here:
BrainStorm Expands Pipeline With Initiation of Pre-Clinical Study in Autism
Scientists from The University of Manchester have identified an important trigger that dictates how cells change their identity and gain specialized functions.
And the research, published in Cell Reports, has brought them a step closer to being able to decode the genome.
The scientists have found out how embryonic stem cell fate is controlled which will lead to future research into how cells can be artificially manipulated.
Lead author Andrew Sharrocks, Professor in Molecular Biology at The University of Manchester, said: "Understanding how to manipulate cells is crucial in the field of regenerative medicine which aims to repair or replace damaged or diseased human cells or tissues to restore normal function."
During the research the team focused on the part of the cellular genome that gives a gene its expression known as the 'enhancer'. This controls the conversion of DNA from genes into useful information that provides the building blocks that determine the structure and function of our cells.
Different enhancers are active in different cell types, allowing the production of distinct gene products and hence a range of alternative cell types. In the current study, the team have determined how these enhancers become active.
Professor Sharrocks said: "All of us develop into complex human beings containing millions of cells from a single cell created by fertilization of an egg. To transit from this single cell state, cells must divide and eventually change their identity and gain specialised functions. For example we need specific types of cells to populate our brains, and our recent work has uncovered the early steps in the creation of these types of cells.
"One of the most exciting areas of regenerative medicine is the newly acquired ability to be able to manipulate cell fate and derive new cells to replace those which might be damaged or lost, either through old age or injury. To do this, we need to use molecular techniques to manipulate stem cells which have the potential to turn into any cell in our bodies."
But one of the current drawbacks in the field of regenerative medicine is that the approaches are relatively inefficient, partly because scientists do not fully understand the basic principles which control cell fate determination.
"We believe that our research will help to make regenerative medicine more effective and reliable because we'll be able to gain control and manipulate cells -- thus our understanding of the regulatory events within a cell shed light on how to decode the genome," concluded Professor Sharrocks.
Original post:
Scientists find trigger to decode the genome
Stem Cell Therapy for Anti-Aging Treatment, How it works?
http://www.placidway.com/package/1023/Affordable-Therapeutic-Treatment-In-Lugano%2C-Switzerland - Antiaging treatments have been and will continue to be a hot topic among men and women of all...
By: placidways
See the article here:
Stem Cell Therapy for Anti-Aging Treatment, How it works? - Video
Doctor uses stem cells
To heal patient.
By: WTNH News8
See the rest here:
Doctor uses stem cells - Video
Institute for Stem Cell and Regenerative Medicine at the University of Washington
Meet the folks behind the impressive discoveries and science occurring at UW Medicine #39;s South Lake Union Research complex. http://depts.washington.edu/iscrm/...
By: UWMedicineHealth
More here:
Institute for Stem Cell and Regenerative Medicine at the University of Washington - Video
Contact Information
Available for logged-in reporters only
Newswise San Antonio, June 10, 2014 Texas Biomedical Research Institute has recruited two new research scientists to its Southwest National Primate Research Center (SNPRC) who will focus on regenerative medicine, working with animal models to develop human stem cell therapies for medical conditions such as Parkinsons disease, degenerative diseases of the eye and muscular dystrophy.
Tiziano Barberi, PhD and Marcel M. Daadi, PhD join Texas Biomed as Associate Scientists in the SNPRC. Barberi comes from the Australian Regenerative Medicine Institute at Monash University in Melbourne, Australia and Daadi arrives from Palo Alto, CA where he was part of the Consulting Faculty of Stanford Universitys Department of Neurosurgery. He is also President and Chief Scientific Officer of NeoNeuron LLC.
Dr. Barberi and Dr. Daadi are significant additions to our regenerative medicine research program, Texas Biomed President and CEO Kenneth P. Trevett said. Both have focused on stem cell research, have published significant research results in peer review journals and received recognition for their leading roles within research teams and at institutions. Regenerative medicine is a major focus for Texas Biomed, where we have new facilities and financial resources dedicated for that purpose, he said. We also look to expand our work with other institutions and groups in San Antonio to promote progress in this field. Dr. Barberi and Dr. Daadi both have strong backgrounds in developing collaborative efforts, and we look forward to the contributions they will make in this important research arena.
Barberi, a native of Italy, had been one of 15 Chief Investigators of the Stem Cells Australia Consortium for stem cell research and Group Leader for the Australian Regenerative Medicine Institute. With a laboratory research focus on the directed differentiation of human pluripotent stem cells (hESC and iPSC) into specific developmental fates, his research aims are to provide tools for human development studies, in vitro disease modeling and a cell therapeutics approach to disease. He described in a seminal work a method to obtain all the clinically relevant neuronal subtypes from mESC, and was the first to have directed differentiation of hESC into mesenchymal precursors and into the progenitor cells forming the skeletal muscle system.
Prior to his work in Australia, Barberi was head of the Laboratory of Stem Cells and Development at the Beckman Research Institute of City of Hope in Duarte, CA. During the time spent at City of Hope, Barberi was awarded the prestigious New Faculty Award from the California Institute for Regenerative Medicine (CIRM). He is an invited reviewer for a number of stem cell-related research journals and is a grant reviewer/assessor for research programs in Canada, Australia, New Zealand and the European Union.
Daadi has unique academia and industry experiences bridging basic and translational research. He comes to Texas Biomed from the San Francisco bay area where he founded a biotechnology company, NeoNeuron, focused on developing therapies for treating neurological disorders. He served as Director of Stem Cell Research, CIRM Disease Team Stroke Neural Transplant Program at Stanford University School of Medicine and Director of the Parkinson's Disease Program at the Sanford Burnham Medical Research Institute, Layton Biosciences Inc and NeuroSpheres LLC.
At Stanford University, Daadi developed a novel technology to purify homogenous populations of neural stem cells from human pluripotent stem cells and coax them to specific types of neurons that can be used for brain repair. His research is paving the way for clinical trials to treat patients with devastating neurological disorders, such as Parkinsons disease, stroke and traumatic brain injury. He seeks to expand on the capabilities of the SNPRC and to build new collaborative programs and projects in stem cell research with colleagues at the University of Texas Health Science Center at San Antonio and the University of Texas at San Antonio.
Daadi serves as editor and reviewer for many peer review journals. He is a permanent member on the National Institutes of Health Grant Review Committee, The Maryland Stem Cell Research Fund and serves on many other national and international Grant Review Committees.
More here:
Texas Biomed Regenerative Medicine Program Expands With Two New Research Scientists
FINITI: Cellular Aging Ends Here
FINITI contains the only proprietary blend of natural ingredients known to safely lengthen short telomeres and maintain healthy stem cells. It also protects your DNA, telomeres, and cells...
By: HealthBeauty@Jeunesse
Original post:
FINITI: Cellular Aging Ends Here - Video
Biochemistry of Stem Cells
By: Global Medical Training Network [GMTN]
Visit link:
Biochemistry of Stem Cells - Video
Dr Nathan Newman Explains LUMINESCE Jeunesse Global
http://renate23.jeunesseglobal.com Dr. Nathan Newman explains how Adult Stem Cells are Revolutionizing medicine and how they #39;re Already being used in treatment of cosmetic and reconstructive...
By: Renate Delaforce
Go here to see the original:
Dr Nathan Newman Explains LUMINESCE Jeunesse Global - Video
Injecting Fat Stem Cells for Breast Augmentation
By: Global Medical Training Network [GMTN]
Read more here:
Injecting Fat Stem Cells for Breast Augmentation - Video
Stem Cells, Binmimetic Polymers, and the Promise of Regenerative Medience: Kevin Healy
By: citrisuc
The rest is here:
Stem Cells, Binmimetic Polymers, and the Promise of Regenerative Medience: Kevin Healy - Video
A deep dive analysis of erythropoietin market
Erythropoietin is a glycoprotein hormone produced in the kidney that stimulates the production of red blood cells by bone marrow stem cells. http://www.bigmarketresearch.com/erythropoietin-market.
By: Big Market Research
The rest is here:
A deep dive analysis of erythropoietin market - Video
How do Stem Cell Therapy Work?
by Danny Yang.
By: Marieke van Lankvelt
More here:
How do Stem Cell Therapy Work? - Video
Beverly HIlls, California (PRWEB) June 09, 2014
The top stem cell doctor in Beverly Hills and Los Angeles at Beverly Hills Orthopedic Institute are now offering stem cell procedures for hip arthritis. The stem cell therapy typically provides pain relief along with being able to delay or avoid the need for joint replacement. Call (310) 438-5343 for more information and scheduling.
Dr. Raj, Medical Director at Beverly Hills Orthopedic Institute, is a Double Board Certified orthopedic doctor who has been a pioneer in stem cell therapy for musculoskeletal conditions. Several types of stem cell procedures are offered including bone marrow derived along with amniotic derived procedures.
For the bone marrow stem cell procedures, a short outpatient procedure involves harvesting bone marrow from the patient's iliac crest. The stem cells are immediately processed to concentrate the growth factors and cells, and then they are injected into the hip for pain relief and tissue regeneration.
For the amniotic derived procedures, the fluid is obtained from consenting donors after a scheduled c-section procedure. There is no fetal tissue utilized, and the fluid is processed at an FDA regulated laboratory. An immense amount of stem cells, growth factors and hyaluronic acid are present in the amniotic material.
Dr. Raj has performed a significant amount of stem cell procedures utilizing both methods for hip arthritis, with the results being stellar to date. Being Double Board Certified and a sports medicine expert, Dr. Raj also offers stem cell procedures for sports injuries such as tendonitis and ligament injuries. This includes rotator cuff tendonitis, knee injuries, elbow tendonitis and more.
Beverly Hills Orthopedic Institute is the premier stem cell clinic in Los Angeles and Beverly Hills. Dr. Raj is an ABC News Medical Correspondent and a WebMD Medical Expert. For information on how stem cell therapy can help, call Beverly Hills Orthopedic Institute at (310) 438-5343.
See the article here:
Beverly Hills Orthopedic Institute Now Offering Revolutionary Stem Cell Procedures for Hip Arthritis to Avoid Joint ...
An Okotoks boy may not understand his community is helping to give him a better life this weekend, but there is a good chance he will be smiling anyway.
At four years old, Ryker Menzies communicates through a series of sounds, suffers from frequent muscle spasms, is in a wheelchair because hes unable to walk or sit on his own and is constantly on painkillers.
This has been Rykers reality since infancy due to a severe case of cerebral palsy, and his parents Tiffany Boyd and Jamie Menzies are hopeful stem cell therapy treatment in Panama City will improve his muscle movement, vision and speech.
Unfortunately, they havent been able to afford the procedure living on one income while Boyd cares for Ryker.
To help pay for the $15,600 treatment, the couple is organizing a mini-market at the Foothills Centennial Centre on June 14 from 11 a.m. to 4 p.m. and inviting the community to check out an abundance of second-hand items and products from home-based and privately-owned businesses for an entry fee of $2.
Money will also be raised through a food vendor, numerous raffle tickets for prizes including vacations and toys, and items donated by residents. Okotoks singer Emily Gryba will perform at the event.
Ive been getting a lot of calls from people donating stuff to the market to sell there, as well as a few online donations, said Boyd. We will just set up about five tables and have family run them. The proceeds will go to Ryker.
Boyd said she is ecstatic at the amount of community support for Rykers stem cell treatment. An online fund she established called Raise for Rykstar collected $1,300, with another $2,000 donated by family, friends and community members.
The feedback has been fantastic, she said. Were already at $3,500.
As the family gets closer to reaching their financial goal, Boyd is eager to book an appointment to give Ryker the best life possible. She said she was told they will have an appointment within a month or two of making the call.
View original post here:
Boy getting a chance for a better life